Category Archives: Top Market News

Adverum Biotechnologies (ADVM) Received its Third Buy in a Row

After SunTrust Robinson and Piper Sandler gave Adverum Biotechnologies (NASDAQ: ADVM) a Buy rating last month, the company received another Buy, this time from Chardan Capital. Analyst Gbola Amusa reiterated a Buy rating on Adverum Biotechnologies today. The company’s shares

The Chief Commercial Officer of GW Pharma is Exercising Options

Today it was reported that the Chief Commercial Officer of GW Pharma (GWPH – Research Report), Darren Cline, exercised options to sell 150 GWPH shares for a total transaction value of $18.97K. Following this transaction Darren Cline’s holding in the

The CAO of Yelp (NYSE: YELP) is Selling Shares

Yesterday, the CAO of Yelp (YELP – Research Report), Laurence Wilson, sold shares of YELP for $42.02K. Following Laurence Wilson’s last YELP Sell transaction on May 21, 2020, the stock climbed by 0.7%. See today’s analyst top recommended stocks >>

A Director at Digirad (NASDAQ: DRAD) is Buying Shares

Yesterday, a Director at Digirad (DRAD – Research Report), Cunnion Michael, bought shares of DRAD for $11.2K. Following this transaction Cunnion Michael’s holding in the company was increased by 49.77% to a total of $33.55K. In addition to Cunnion Michael,

Mizuho Securities Reaffirms Their Buy Rating on CytomX Therapeutics (CTMX)

In a report released yesterday, Mara Goldstein from Mizuho Securities maintained a Buy rating on CytomX Therapeutics (CTMX – Research Report), with a price target of $16.00. The company’s shares closed last Friday at $8.86. According to, Goldstein is

A Director at Epam Systems (NYSE: EPAM) is Selling Shares

Yesterday, a Director at Epam Systems (EPAM – Research Report), Ronald Vargo, sold shares of EPAM for $337.2K. Following Ronald Vargo’s last EPAM Sell transaction on December 03, 2019, the stock climbed by 23.0%. In addition to Ronald Vargo, 14